iSpecimen (ISPC) Return on Equity (2021 - 2025)
iSpecimen (ISPC) has 5 years of Return on Equity data on record, last reported at 6.65% in Q3 2025.
- For Q3 2025, Return on Equity fell 486.0% year-over-year to 6.65%; the TTM value through Sep 2025 reached 6.65%, down 486.0%, while the annual FY2024 figure was 1.97%, 125.0% down from the prior year.
- Return on Equity reached 6.65% in Q3 2025 per ISPC's latest filing, up from 9.75% in the prior quarter.
- Across five years, Return on Equity topped out at 0.52% in Q2 2021 and bottomed at 9.75% in Q2 2025.
- Average Return on Equity over 5 years is 1.75%, with a median of 0.68% recorded in 2023.
- Peak YoY movement for Return on Equity: grew 16bps in 2022, then plummeted -818bps in 2025.
- A 5-year view of Return on Equity shows it stood at 0.22% in 2021, then tumbled by -114bps to 0.48% in 2022, then plummeted by -101bps to 0.97% in 2023, then crashed by -232bps to 3.2% in 2024, then tumbled by -108bps to 6.65% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Equity were 6.65% in Q3 2025, 9.75% in Q2 2025, and 4.63% in Q1 2025.